Christopher Friedel
Keine laufenden Positionen mehr
Karriereverlauf von Christopher Friedel
Ehemalige bekannte Positionen von Christopher Friedel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
APONTIS PHARMA AG | Direktor/Vorstandsmitglied | 01.01.2021 | 12.05.2022 |
Jazz Pharmaceuticals Germany GmbH
Jazz Pharmaceuticals Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Germany GmbH is a company committed to advancing clinical knowledge through various types of research, including non-interventional studies. The company is based in Munich, Germany. The company adheres to established regulations, industry best practices, and internal policies to ensure the integrity of their sponsored research. Jazz Pharmaceuticals Germany is focused on improving patients' lives by developing and commercializing products that address unmet medical needs. The CEO of the company is Iain Robert McGill. | Vorstandsvorsitzender | 01.12.2020 | - |
Ausbildung von Christopher Friedel
University of Gottingen | Doctorate Degree |
Statistik
International
Deutschland | 4 |
Operativ
Director/Board Member | 1 |
Doctorate Degree | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
APONTIS PHARMA AG | Health Technology |
Private Unternehmen | 1 |
---|---|
Jazz Pharmaceuticals Germany GmbH
Jazz Pharmaceuticals Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Germany GmbH is a company committed to advancing clinical knowledge through various types of research, including non-interventional studies. The company is based in Munich, Germany. The company adheres to established regulations, industry best practices, and internal policies to ensure the integrity of their sponsored research. Jazz Pharmaceuticals Germany is focused on improving patients' lives by developing and commercializing products that address unmet medical needs. The CEO of the company is Iain Robert McGill. | Health Technology |
- Börse
- Insiders
- Christopher Friedel
- Erfahrung